Rchr
J-GLOBAL ID：201901014452959174   Update date: Jan. 30, 2024

Zhou Yue

Zhou Yue
Research field  (1)： Pharmaceuticals - health and biochemistry
Research keywords  (2)： 受容体型チロシンキナーゼ ,  シグナル伝達
Research theme for competitive and other funds  (4)：
  • 2022 - 2025 MK2を介した非定型的活性型EphA2によるがん悪性進展の制御機構
  • 2022 - 2025 Cancer pathophysiology and treatment from the perspective of dual-mode control of EGFR
  • 2020 - 2023 がん微小環境におけるVEGFR3非定型的活性化機構の解明
  • 2019 - 2021 Regulation of epithelial-mesenchymal transition and cancer stemness by the non-canonical activation of EphA2.
Papers (40)：
  • Jun-Ichiro Takahashi, Shiori Nakamura, Iimi Onuma, Yue Zhou, Satoru Yokoyama, Hiroaki Sakurai. Synchronous intracellular delivery of EGFR-targeted antibody-drug conjugates by p38-mediated non-canonical endocytosis. Scientific reports. 2022. 12. 1. 11561-11561
  • Yue Zhou, Hiroaki Sakurai. New trend in ligand-induced EGFR trafficking: A dual-mode clathrin-mediated endocytosis model. Journal of proteomics. 2022. 255. 104503-104503
  • Keisuke Yonehara, Yue Zhou, Jun-Ichiro Takahashi, Satoru Yokoyama, Kei Tomihara, Makoto Noguchi, Hiroaki Sakurai. RSK-Mediated Non-canonical Activation of EphA2 by Tamoxifen. Biological & pharmaceutical bulletin. 2022. 45. 2. 162-168
  • Yamagishi N, Takahashi JI, Zhou Y, Yokoyama S, Makino T, Shimizu T, Sakurai H. Non-canonical Regulation of EGFR by the Air Pollutant 9,10-Phenanthrenequinone. Biological & pharmaceutical bulletin. 2022
  • Satoru Yokoyama, Atsushi Takahashi, Ryota Kikuchi, Soshi Nishibu, Jennifer A Lo, Miroslav Hejna, Wooyoung M Moon, Shinichiro Kato, Yue Zhou, F Stephen Hodi, et al. SOX10 Regulates Melanoma Immunogenicity through an IRF4-IRF1 Axis. Cancer research. 2021. 81. 24. 6131-6141
ｍore...
MISC (4)：
  • Jibran Sualeh Muhammad, Syed Faisal Zaidi, Yue Zhou, Hiroaki Sakurai, Toshiro Sugiyama. Release of Human beta-Defensin 3 From Gastric Epithelial Cells Infected With Helicobacter pylori by Novel EGFR Phosphorylation via p38/ERK Activation. GASTROENTEROLOGY. 2014. 146. 5. S503-S503
  • 周越, 山田直樹, 田中智大, 櫻井宏明. RSK-EphA2シグナルを介したがん細胞運動の制御機構. 日本がん転移学会学術集会・総会プログラム抄録集. 2014. 23rd
  • 田中 智大, 周 越, 河崎 優希, 佐久間 勉, 櫻井 宏明. p38を介したセリン残基のリン酸化によるEGFRの細胞内輸送機構. 生化学. 2013. 85. 6. 498-498
  • 田中 智大, 周 越, 中 明叔, 河崎 優希, 佐久間 勉, 済木 育夫, 櫻井 宏明. リガンド濃度に依存したEGF受容体の多次元的リン酸化制御. 生化学. 2012. 84. 7. 604-604
Education (3)：
  • 2011 - 2014 University of Toyama Graduate School of Medicine and Pharmaceutical Sciences for Education
  • 2009 - 2011 University of Toyama Graduate School of Medicine and Pharmaceutical Sciences for Education
  • 2005 - 2009 University of Toyama Faculty of Pharmacy and Pharmaceutical Sciences
Professional career (1)：
  • 博士(薬学) (富山大学)
Work history (5)：
  • 2019/04 - 現在 University of Toyama
  • 2016/01 - 2019/03 上海中医薬大学 中薬研究所 副研究員
  • 2015/04 - 2015/12 Osaka University Graduate School of Medicine
  • 2014/07 - 2015/03 University of Toyama Graduate School of Medicine and Pharmaceutical Sciences for Research
  • 2014/04 - 2014/06 University of Toyama Graduate School of Medicine and Pharmaceutical Sciences for Research
Association Membership(s) (4)：
日本がん転移学会 ,  THE MOLECULAR BIOLOGY SOCIETY OF JAPAN ,  THE JAPANESE ASSOCIATION FOR MOLECULAR TARGET THERAPY OF CANCER ,  THE JAPANESE CANCER ASSOCIATION
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM